BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology
News
February 16, 2017
London, UK: BTG plc (LSE: BTG), the global specialist healthcare company, today announced a collaboration with the Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, to explore the role of interventional oncology alongside immuno-oncology.